[15] Semaglutide is a peptide similar to the hormone glucagon-like peptide-1 (GLP-1), modified with a side chain, and acts as a GLP-1 receptor agonist
Glucagon-like peptide-1 (GLP-1) receptor agonists represent a class of medications originally developed for type 2 diabetes management and now widely prescribed for chronic weight management
Myth: Hair turns grey because of a lack of calcium
GLP-1 shots, including medications like semaglutide GLP-1 and Tirzepatide , typically begin working within a few weeks of starting treatment, although the rate at which weight loss occurs can vary between individuals
GLP-1 agonists are currently FDA-approved for the treatment of obesity due to their weight loss effects
They are prepared by licensed pharmacies under federal and state compounding rules and are not reviewed by the FDA for safety, effectiveness, or quality before dispensing